Aveanna Healthcare Holdings, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

647.91

662.48

621.94

589.55

559.22

519.87

509.02

Other Operating Income

0.00

Total Operating income

647.91

662.48

621.94

589.55

559.22

519.87

509.02

Raw Material Cost

445.53

451.91

421.72

381.37

378.26

350.60

351.91

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

29.16

32.62

35.13

36.00

36.34

38.10

39.24

Selling and Distribution Expenses

126.44

132.17

143.53

127.62

127.17

120.84

117.16

Other Expenses

-2.92

-3.26

-3.51

-3.60

-3.63

-3.81

-3.92

Total Expenditure (Excl Depreciation)

571.98

584.08

565.25

508.99

505.43

471.44

469.07

Operating Profit (PBDIT) excl Other Income

75.9

78.4

56.7

80.60000000000001

53.8

48.4

Other Income

5.45

6.74

6.98

6.08

6.28

7.59

9.89

Operating Profit (PBDIT)

89.04

91.19

70.38

93.46

66.86

63.23

54.33

Interest

29.16

32.62

35.13

36.00

36.34

38.10

39.24

Exceptional Items

-7.26

-12.15

-14.71

-6.35

-13.43

9.01

-35.07

Gross Profit (PBDT)

202.38

210.57

200.22

208.18

180.96

169.28

157.11

Depreciation

7.65

7.18

7.13

6.97

6.95

7.20

7.35

Profit Before Tax

44.98

39.24

13.42

44.14

10.15

26.93

-27.33

Tax

3.32

-139.51

-0.65

17.11

4.96

-2.25

15.51

Provisions and contingencies

0.00

Profit After Tax

41.65

178.75

14.06

27.02

5.19

29.18

-42.84

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

41.65

178.75

14.06

27.02

5.19

29.18

-42.84

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

41.65

178.75

14.06

27.02

5.19

29.18

-42.84

Equity Capital

0.00

Face Value

0.01

Reserves

240.05

194.46

9.18

-11.99

-100.13

-123.55

-156.44

Earnings per share (EPS)

0.19

0.8

0.06

0.13

0.03

0.14

-0.22

Diluted Earnings per share

0.19

0.8

0.06

0.13

0.03

0.14

-0.22

Operating Profit Margin (Excl OI)

11.72%

11.66%

9.05%

13.64%

9.59%

9.32%

7.29%

Gross Profit Margin

8.12%

7.01%

3.3%

8.67%

3.06%

6.57%

-3.93%

PAT Margin

6.43%

26.98%

2.26%

4.58%

0.93%

5.61%

-8.42%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.20% vs 6.53% in Dec 2025

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -76.68% vs 1,168.09% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -1.07% vs 33.28% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -10.43% vs -7.12% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Aveanna Healthcare Holdings, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(USD)

Change(%)

Net Sales

647.91

50.16

597.75

1,191.69%

Other Operating Income

0.00

Total Operating income

647.91

50.16

597.75

1,191.69%

Raw Material Cost

445.53

7.60

437.93

5,762.24%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

10.75

-10.75

-100.00%

Power Cost

0.00

Manufacturing Expenses

29.16

0.00

29.16

Selling and Distribution Expenses

126.44

48.19

78.25

162.38%

Other Expenses

-2.92

-1.06

-1.86

-175.47%

Total Expenditure (Excl Depreciation)

571.98

55.91

516.07

923.04%

Operating Profit (PBDIT) excl Other Income

75.94

-5.75

81.69

1,420.70%

Other Income

5.45

0.06

5.39

8,983.33%

Operating Profit (PBDIT)

89.04

-6.88

95.92

1,394.19%

Interest

29.16

0.00

29.16

Exceptional Items

-7.26

0.00

-7.26

Gross Profit (PBDT)

202.38

42.56

159.82

375.52%

Depreciation

7.65

2.00

5.65

282.50%

Profit Before Tax

44.98

-8.87

53.85

607.10%

Tax

3.32

0.00

3.32

Provisions and contingencies

0.00

Profit After Tax

41.65

-8.87

50.52

569.56%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

41.65

-8.87

50.52

569.56%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

41.65

-8.87

50.52

569.56%

Equity Capital

0.00

Face Value

0.01

0.00

Reserves

240.05

15.04

225.01

1,496.08%

Earnings per share (EPS)

0.19

-0.20

0.39

195.00%

Diluted Earnings per share

0.19

-0.20

0.39

195.00%

Operating Profit Margin (Excl OI)

11.72%

-17.80%

0.00

29.52%

Gross Profit Margin

8.12%

-13.71%

0.00

21.83%

PAT Margin

6.43%

-17.69%

0.00

24.12%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 64.79 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -2.20% vs 6.53% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 15.86% vs 13.96% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 4.17 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -76.68% vs 1,168.09% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 701.92% vs 146.43% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 8.36 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -1.07% vs 33.28% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 37.95% vs 71.67% in Mar 2025

Quarterly - Interest

Interest 2.92 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -10.43% vs -7.12% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -19.56% vs -8.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 11.72%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025